Welcome to our dedicated page for Opgen SEC filings (Ticker: CFOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Opgen's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Opgen's regulatory disclosures and financial reporting.
CapForce Inc. filed a Form 12b-25 Notification of Late Filing stating it cannot timely file its Annual Report on Form 10-K for the period ended December 31, 2025. The delay is attributed to valuation and purchase price allocation work related to the previously disclosed acquisition of iCapX Sdn. Bhd. and limited internal accounting personnel. The company expects to file the Form 10-K within the fifteen calendar day extension permitted by Rule 12b-25.